Abstract
Objective: The aim of the work was to enhance the dissolution rate of rivaroxaban by preparing its solid dispersions (SDs) using hydrophilic carrier PEG 4000.
Methods: The SDs of rivaroxaban with PEG 4000 were prepared at 1:1, 1:2 and 1:3 w/w ratios by physical mixing, melting and solvent evaporation techniques. The prepared solid dispersions were characterized by Fourier-transform infrared spectroscopy (FTIR) and differential scanning calorimetry (DSC).
Results: Both the solubility and dissolution rate of the drug in these formulations were increased. The used hydrophilic carriers showed a more than two-fold increase in dissolution rate in their prepared solid dispersions by melting or solvent evaporation techniques. The pure drug rivaroxaban as the pure drug shows a dissolution rate of nearly 39 % after 60 m, whereas the solid dispersions by melting or solvent evaporation showed 90% of dissolution after 60 m. The FTIR spectroscopic and DCS thermal studies showed the compatibility of rivaroxaban and the absence of well-defined drug polymer interactions, though the shift in peaks was observed due to the formation of new bonds.
Conclusion: Formulation of solid dispersions of drug with hydrophilic carriers is a successful approach for solubility or dissolution rate enhancement of low soluble drug(s). In this work for solubility enhancement of rivaroxaban the hydrophilic carrier PEG 4000 showed significant solubility enhancement.
Publisher
Innovare Academic Sciences Pvt Ltd
Reference22 articles.
1. Choi M, Woo MR, Choi H, Jin SG. Effects of polymers on the drug solubility and dissolution enhancement of poorly water-soluble Rivaroxaban. Int J Mol Sci. 2022 Aug 22;23(16):9491. doi: 10.3390/ijms23169491.
2. Chen N, Di P, Ning S, Jiang W, Jing Q, Ren G. Modified rivaroxaban microparticles for solid-state properties improvement based on drug-protein/polymer supramolecular interactions. Powder Technol. 2019;344:819-29. doi: 10.1016/j.powtec.2018.12.085.
3. Choi MJ, Kim JS, Yu HS, Woo MR, Choi JE, Baek KH. Comparison of the physicochemical properties, aqueous solubility, and oral bioavailability of Rivaroxaban loaded-high pressure-homogenized and Shirasu porous glass membrane emulsified solid self nano emulsifying drug delivery systems. J Mol Liq. 2021;23:117057.
4. Mahapatra AK, Murthy PN, Erla RR, Soujany SP, Patra RK. An updated review on technical advances to enhance the dissolution rate of hydrophobic drugs. Int Res J Pharm. 2012;3(10).
5. Mahapatra AK, Murthy PN, Patra RK, Panda S, Rautray RK. Comparative interaction of β-cyclodextrin and 2-hydroxypropyl-β-cyclodextrin with fenofibrate: phase-solubility behavior and dissolution rates. Lat Am J Pharm. 2012;31(9):1302-9.